Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

Amyloidosis Program Treatment Team

  • Giada Bianchi, MD, and Rodney Falk, MD

  • In the Amyloidosis Program at Dana-Farber and Brigham and Women's Hospital, our dedicated experts work together across a range of specialty areas to coordinate fully integrated, personalized care. Team members are actively involved in research to advance the treatment options and our understanding of this disease.


    Giada Bianchi, MD, Associate Program Director

    Giada Bianchi, MD, is on the faculty and is a physician scientist in the Hematologic Malignancies Division of Dana-Farber Cancer Institute. Her clinical interest is in plasma cell disorders, particularly AL amyloidosis, multiple myeloma, monoclonal gammopathy of renal significance and multiple myeloma. In the laboratory, Bianchi's research focus is on mechanisms governing protein homeostasis in plasma cell disorders and their impact on AL amyloidosis and multiple myeloma pathogenesis and progression.

    Rodney H. Falk, MD, Amyloidosis Program Director

    Rodney Falk, MD, is a world-renowned expert in cardiac amyloidosis. A cardiologist and amyloidosis specialist, Falk leads the Cardiac Amyloidosis Program at Brigham and Women's Hospital and brings his exceptional expertise in diagnosis and treatment — as well as his passion for ongoing medical science discovery in this area — to patients with AL amyloidosis.

    Care Team Members

    Jacob Laubach, MD, MPP
    Albert Lam, MD
    Shannon Miller, NP